US Bancorp’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

US Bancorp’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-500	Closed	-$25.3K	–	4209
2024 Q4	$25.3K	Hold	500	–	–	﹤0.01%	3062
2024 Q3	$31.9K	Hold	500	–	–	﹤0.01%	2951
2024 Q2	$29.6K	Hold	500	–	–	﹤0.01%	2899
2024 Q1	$28.8K	Hold	500	–	–	﹤0.01%	2942
2023 Q4	$28.5K	Hold	500	–	–	﹤0.01%	2913
2023 Q3	$24K	Hold	500	–	–	﹤0.01%	2794
2023 Q2	$26K	Hold	500	–	–	﹤0.01%	2843
2023 Q1	$27.1K	Hold	500	–	–	﹤0.01%	2829
2022 Q4	$28.9K	Hold	500	–	–	﹤0.01%	2806
2022 Q3	$23K	Hold	500	–	–	﹤0.01%	2950
2022 Q2	$25K	Hold	500	–	–	﹤0.01%	2924
2022 Q1	$31K	Hold	500	–	–	﹤0.01%	2837
2021 Q4	$40K	Sell	500 -37	-7%	-$3.17K	﹤0.01%	2761
2021 Q3	$51K	Hold	537	–	–	﹤0.01%	2644
2021 Q2	$53K	Buy	537 +37	+7%	+$3.23K	﹤0.01%	2637
2021 Q1	$42K	Hold	500	–	–	﹤0.01%	2660
2020 Q4	$43K	Hold	500	–	–	﹤0.01%	2572
2020 Q3	$35K	Hold	500	–	–	﹤0.01%	2556
2020 Q2	$36K	Hold	500	–	–	﹤0.01%	2548
2020 Q1	$23K	Hold	500	–	–	﹤0.01%	2682
2019 Q4	$31K	Buy	+500	New	+$26.7K	﹤0.01%	2687

Other funds holding BIB

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return

WWM

Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

PSFG

Park Square Financial Group Roswell, Georgia $13.2M AUM 23.63% 1-Year Est. Return

US Bancorp's BIB Position: Q1 2025 in Review

US Bancorp sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q1 2025, closing a stake of 500 shares — an estimated $25.3K sold.

US Bancorp first reported a position in BIB in Q4 2019 and held it in 21 quarters. The position peaked at $53K in Q2 2021. 23 funds tracked by Wall St. Rank hold BIB as of Q1 2025.

US Bancorp reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q1 2025 after selling out during the quarter.
US Bancorp sold 500 ProShares Ultra NASDAQ Biotechnology shares in Q1 2025, an estimated $25.3K.
US Bancorp first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2019 and held it in 21 quarters.
US Bancorp's ProShares Ultra NASDAQ Biotechnology position peaked at $53K in Q2 2021.
23 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2025.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.